Advertisement
Advertisement

PBH

PBH logo

Prestige Consumer Healthcare Inc.

49.79
USD
Sponsored
-2.47
-4.73%
Sep 08, 16:00 UTC -4
Closed
exchange

After-Market

47.53

-2.26
-4.54%

Prestige Consumer Healthcare Inc. Profile

About

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.

Info & Links

CEO

Ronald M. Lombardi

Headquarters

660 WHITE PLAINS ROAD
TARRYTOWN, NY 10591, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.prestigebrands.com

Auditor

PricewaterhouseCoopers LLP

Share holders

14

Employees

890

Prestige Consumer Healthcare Inc. Statistics

Valuation Measures

Market Capitalization2

2.25B

Enterprise Value

4.20B

Enterprise Value/EBITDA(ttm)

12.95

Price to Earnings Ratio(ttm)

11.82

Price to Sales(ttm)

2.24

Price to Book(mrq)

1.29

Price to Cash(ytd)

10.03

Profitability

Gross Margin(ttm)

53.51%

Operating Margin(ttm)

19.22%

Profit Margin(ttm)

15.50%

Return on Equity(ttm)

11.39%

Return on Invested Capital(ttm)

5.71%

Return on Assets(ttm)

5.66%

Income Statement

Revenue(ttm)

1.10B

Revenue Per Share(ttm)

23.32

Gross Profit(ttm)

591.43M

EBITDA(ttm)3

324.35M

Net Income Available to Common(ttm)

172.01M

Diluted EPS(ttm)

3.57

Share Statistics

Beta (5Y Monthly)

0.33

52-Week Change

-23.46%

S&P 500 52-Week Change

18.98%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

47.37M

Dividend Yield

0.00%

Float4

46.66M

% Held by Insiders

1.50%

% Held by Institutions

99.95%

Balance Sheet

Total Cash(mrq)

89.13M

Total Cash Per Share(mrq)

1.88

Total Debt(mrq)

2.04B

Total Debt/Equity(mrq)

106.31%

Current Ratio(mrq)

3.23%

Quick Ratio(mrq)

1.99%

Book Value Per Share(mrq)

40.46

Cash Flow

Operating Cash Flow Per Share(ytd)

1.49

Free Cash Flow(ytd)

67.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement